Valneva Shares Topple As It Hits Ethics Roadblock With Pfizer In Lyme Disease Test

stock plummeted Friday after Pfizer (PFE) said it will drop roughly half of the participants enrolled in the companies' Lyme disease vaccine study. The decision comes after Pfizer found violations of "good clinical practice" rules at study sites run by a third-party operator. These rules safeguard…#pfe #lyme #gcp #valneva #pfizer #phase3 #clinicaltrialsgov #vla15 #marketsmithcom #apatentcliffiscoming
Source: Reuters: Health - Category: Consumer Health News Source Type: news